Pharmaceutical composition for treating cutaneous burns
Assignee45 Sec. LLC
InventorJean-Jacques Debetencourt
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition characterized in that the composition contains at least 4 wt % relative to the total weight of the composition of an active principle selected from among cetearyl octanoate and hexanoic acid, beeswax and optionally one or more pharmaceutically acceptable excipient(s), as well as to the use thereof for the treatment of cutaneous pre-burns or burns and for reducing pain following a thermal shock.
Claims21
A pharmaceutical composition comprising at least 4% by weight, relative to the total weight of the composition, of an active ingredient chosen from cetearyl octanoate and/or hexanoic acid, in combination with beeswax and, optionally, one or more pharmaceutically acceptable excipient(s).
A therapeutic treatment method for reducing the intensity of pain caused by a thermal shock, wherein the pharmaceutical composition is brought into contact with the cutaneous injuries within a period of less than or equal to 60 seconds starting from the contact with the cause of the cutaneous pre-burn or burn in the case of a topical administration, or within a period of less than or equal to 30 minutes in the case of an administration by injection.
Dependencies are inferred from the claim text.